Compassion Center honors Danford "DanK" Koozer on his 80th birthday, recognizing his decades of fearless advocacy, grassroots leadership, and unwavering dedication to cannabis education through Willamette Valley NORML, Emerald Empire Hempfest, and over 750 episodes of Eugene Cannabis TV. His legacy continues to inspire a movement.

Dr. Joanna Kam integrates advanced incision placement strategies in facelift procedures to optimize aesthetic outcomes and reduce scarring.

Michael Mindari, Legal Hemp Expert

As a leader in integrative mental health and the nation's first legal psilocybin therapy center, Bionic Bloom's mission aligns seamlessly with Cannadelic's commitment to holistic well-being and cutting-edge therapies.

Dr. Andy Gaertner of Bliss Dental in Kendall, FL, details a comprehensive smile makeover process, enhancing both aesthetics and oral health.

Subsequent phase involves completion of chemistry, manufacturing, and controls (CMC) testing for data to support FDA submission

Company expects to commence bioavailability study in April 2025

Aspire intends to request "fast track" approval on FDA application for its high dose aspirin product
 

A six-part series to tackle key challenges facing health plans, such as health equity, maternal and behavioral health, quality ratings, and chronic disease management

Dr. Alisa Yamasaki at Yamasaki Facial Plastic Surgery in New Jersey, emphasizes customized rhinoplasty plans for optimal facial balance and functionality.

Clade I, the culprit in the current 2025 version of global epidemic mpox, is highly transmissible and is spreading within families and among children, whereas the 2022 Clade II mpox - still spreading - infects mostly gay men

Addition of Arielle Bernhardt, MSN, APRN

Deep plane facelift expert Dr. Andres Bustillo emphasizes the importance of surgeon skill in achieving optimal outcomes.

Dr. Anni Wong discusses strategies to effectively repair earlobes affected by gauges, tears, and aging, helping patients in Freehold, NJ achieve restored comfort and confidence.

Telomir-1 Inhibits Tumor Growth, Suppresses Cancer Progression, and Neutralizes Chemotherapy Toxicity

Beyond Awareness to Bold Action - ESSE Care Launches #BeyondEndoAwareness Initiative to Cut Diagnosis Delays and Demand Better Endometriosis Care

Company Executes Against M&A Plan, Reiterates $50M+ Pro Forma Guidance, Additional $15M+ Revenue Deal that is expected to increase guidance; Institutional Investor Backing, Exclusive Distribution Agreements & Repeat Sales

viemaa tribe: A Revolutionary Hair Care Community Dedicated to Empowering Healthy, Beautiful Hair

Offered by the American Society of Consultant Pharmacists in partnership with the Lamy Center at the University of Maryland School of Pharmacy

Campaign honors women leaders, their achievements, and forward-thinking attributes for the next generation of insurance and financial services industry leaders

New 45-Minute Sound Therapy Sessions Following Ketamine Treatment Offer Deeper Relaxation, Emotional Release, and Enhanced Healing

Reverse split approved at March 2025 Special Meeting of Stockholders

Shares of Jaguar Health common stock to begin trading on split-adjusted basis on March 24, 2025

Continues focus on development of bispecific anti-cancer agents with differentiated mechanisms of action

Early intervention plays a critical role in preventing further infections, nail damage, and potential complications.

~ Analgesic Experts Consider Pain Indications Versus New Classes of Analgesics ~

~ Panel Discussion Posted to Ensysce's Corporate Website ~

Past Winners include Waymo, Nvidia, Duolingo, and Novo Nordisk, among others

- Dermata expects to announce topline results from its XYNGARI™ Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial by end of March 2025 -

- The Company recently entered into a Clinical Trial Collaboration Agreement with Revance Therapeutics (recently merged with Crown Laboratories) to study DMT410 for the treatment of axillary hyperhidrosis - 

- Raised $2.55 million in gross proceeds from a private placement financing in January 2025, including participation from Dermata's Chief Executive Officer, Chief Financial Officer, and certain members of the Company's board of directors -

The creators of the sam® sustained acoustic medicine technology present its proven ability to speed recovery and soft tissue healing at the University of Louisiana basketball game, part of the company's commitment to helping athletes stay healthy.

Venerable, Popular Destination to Introduce Hypha Labs to Canadian and U.S. Investors

MedSmart Wellness Centers Inc. Signs Letter of Intent to Acquire 3,000 Sq. Ft. Facility in Tequesta, Florida

Monogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).

The Company is Preparing for Commercialization and Evaluating Strategies to Support the Adoption of its Robotic-Assisted Technology

America's Accountant® Daniel J. Geltrude Teams Up with Furry Friends to Teach That Dogs Are Business-Savvy

Electronic Caregiver Opens Nationwide Direct Sales Opportunities for Female Entrepreneurs

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion disease